Clinical trials
Terminated Sarcoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
179 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 7 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 5 |
| 2005 | 6 |
| 2006 | 3 |
| 2007 | 5 |
| 2008 | 7 |
| 2009 | 9 |
| 2010 | 8 |
| 2011 | 6 |
| 2012 | 7 |
| 2013 | 3 |
| 2014 | 8 |
| 2015 | 9 |
| 2016 | 12 |
| 2017 | 9 |
| 2018 | 10 |
| 2019 | 11 |
| 2020 | 10 |
| 2021 | 12 |
| 2022 | 9 |
| 2023 | 5 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 179 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 15 |
| Gynecologic Oncology Group | 6 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 6 |
| Washington University School of Medicine | 6 |
| City of Hope Medical Center | 4 |
| European Organisation for Research and Treatment of Cancer - EORTC | 4 |
| Mayo Clinic | 4 |
| Memorial Sloan Kettering Cancer Center | 4 |
| Pfizer | 4 |
| Balgrist University Hospital | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sarcoma | 179 |
| Melanoma | 30 |
| Breast Neoplasms | 25 |
| Neoplasms | 23 |
| Ovarian Neoplasms | 20 |
| Colorectal Neoplasms | 19 |
| Neoplasm Metastasis | 18 |
| Pancreatic Neoplasms | 17 |
| Lung Neoplasms | 16 |
| Osteosarcoma | 16 |
Trials
Showing 26 to 50 of 179. Each trial links to its page on Pharma Observatory.
79 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.